02/24/2025
3:05 PM | Atossa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
3:09 PM | Atossa Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
02/04/2025
8:00 AM | Atossa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
8:05 AM | Atossa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
12:32 PM | Atossa Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
10:27 AM | Atossa Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
5:35 AM | Atossa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
2:24 PM | Atossa Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
08/12/2024
8:00 AM | Atossa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
8:05 AM | Atossa Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/23/2024
11:15 PM | Atossa Therapeutics (Filer)
| Form EFFECT | |
05/23/2024
8:00 AM | Atossa Therapeutics (Filer)
| Form DEF 14A | |
05/14/2024
3:46 PM | Atossa Therapeutics (Filer)
| Form DEL AM | |
05/13/2024
8:00 AM | Atossa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
8:05 AM | Atossa Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024
8:00 AM | Atossa Therapeutics (Filer)
| Form PRE 14A | |
05/10/2024
8:04 AM | Atossa Therapeutics (Filer)
| Form ARS | |
03/18/2024
7:35 AM | Atossa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2024
7:30 PM | Atossa Therapeutics (Issuer)
Cigler Tessa (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/14/2024
7:35 PM | Atossa Therapeutics (Issuer)
Cigler Tessa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:30 AM | Atossa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free ATOS Stock Alerts